Antiphospholipid antibodies in response to infection

Current Rheumatology Reports

Volumn 9, Issue 3, 2007, Pages 212-218

  Avčin, Tadej ^a   Toplak, Nataša ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BUDD CHIARI SYNDROME; CHICKENPOX; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENTEROBACTER INFECTION; ERYTHEMA INFECTIOSUM; GASTROENTERITIS; GRAM NEGATIVE INFECTION; HEPATITIS; HEPATITIS B; HERPES; HUMAN; IMMUNOBIOLOGY; INFECTION; INFLUENZA; LEISHMANIASIS; LEPROSY; MALARIA; MUMPS; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFECTION; REVIEW; RUBELLA; SPLEEN INFARCTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SYPHILIS; THROMBOSIS; TUBERCULOSIS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY FORMATION; ANTIPHOSPHOLIPID SYNDROME; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; PARASITIC DISEASES; VIRUS DISEASES;

EID: 34250713249     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-007-0034-x     Document Type: Review

References (55)

1. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002, 346:752-763.
2. Cervera R, Asherson RA, Acevedo ML, et al.: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004, 63:1312-1317. A review of 100 APS cases associated with infections.
3. Shoenfeld Y, Blank M, Cervera R, et al.: Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006, 65:2-6. A comprehensive review of experimental models for an infectious origin of APS.
4. Luong TH, Rand JH, Wu XX, et al.: Seasonal distribution of antiphospholipid antibodies. Stroke 2001, 32:1707-1711.
5. Avcin T, Ambrozic A, Kuhar M, et al.: Anticardiolipin and anti-beta2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001, 40:565-573.
6. McNally T, Purdy G, Mackie IJ, et al.: The use of an anti-beta2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995, 91:471-473.
7. Asherson RA, Cervera R, Piette JC, et al.: Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 2001, 80:355-377.
8. Kratz C, Mauz-Körholz C, Kruck H, et al.: Detection of antiphospholipid antibodies in children and adolescents. Pediatr Hematol Oncol 1998, 15:325-332.
9. Frauenknecht K, Lackner K, von Landenberg P: Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection. Immunobiology 2005, 210:799-805.
10. Vaarala O, Palosuo T, Kleemola M, Aho K: Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986, 41:8-15.
11. Von Landenberg P, Lehmann HW, Knoll A, et al.: Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003, 48:1939-1947.
12. Loizou S, Cazabon JK, Walport MJ, et al.: Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997, 40:103-108.
13. Kalt M, Gertner E: Antibodies to beta2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J Rheumatol 2001, 28:2335-2336.
14. Reitblat T, Drogenikov T, Sigalov I, et al.: Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am J Med 2000, 109:512-513.
15. Asano Y, Sarukawa M, Idezuki T, et al.: Multiple small pulmonary emboli associated with transitient antiphospholipid syndrome in human parvovirus B19 infection. Clin Rheumatol 2006, 25:585-587.
16. Labarca JA, Rabaggliati RM, Radrigan FJ, et al.: Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997, 24:197-200.
17. Uthman I, Tabbarah Z, Gharavi AE: Hughes syndrome associated with cytomegalovirus infection. Lupus 1999, 8:775-777.
18. Delbos V, Abgueguen P, Chennebault JM, et al.: Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 2007, 54:e47-50.
19. Viseux V, Darnige L, Carmi E, et al.: Pulmonary embolism and transitory anti-beta2-GPI antibodies in an adult with chicken pox. Lupus 2000, 9:558-560.
20. Van Hal S, Senanayake S, Hardiman R: Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J Clin Virol 2005, 32:245-247.
21. Losurdo G, Giacchino R, Castagnola E, et al.: Cerebrovascular disease and varicella in children. Brain Dev 2006, 28:366-370.
22. Manco-Johnson MJ, Nuss R, Key N, et al.: Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996, 128:319-323.
23. Campanelli A, Kaya G, Ozsahin AH, et al.: Purpura fulminans in a child as a complication of chickenpox infection. Dermatology 2004, 208:262-264.
24. Ordi-Ros J, Villarreal J, Monegal F, et al.: Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000, 7:241-244.
25. Dalekos GN, Kistis KG, Boumba DS, et al.: Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000, 12:67-74.
26. Zachou K, Liaskos C, Christodoulou DK, et al.: Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 2003, 33:161-168.
27. Muñoz-Rodríguez FJ, Tassies D, Font J, et al.: Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999, 30:770-773.
28. Harada M, Fujisawa Y, Sakisaka S, et al.: High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000, 35:272-277.
29. Ertem D, Acar Y, Pehlivanoglu E: Autoimmune complications associated with hepatitis A virus infection in children. Pediatr Infect Dis J 2001, 20:809-811.
30. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E: Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001, 60:500-504.
31. Bloom EJ, Abrams DI, Rodgers G: Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986, 256:491-493.
32. De Larranaga GF, Forastiero RR, Carreras LO, Alonso BS: Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999, 96:19-25.
33. Hassoun A, Al-Kadhimi Z, Cervia J: HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS 2004, 18:333-340.
34. Shah I, Chudgar P: Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child. Pediatr Infect Dis J 2006, 25:185-186.
35. Smith KJ, Skelton HG, Yeager J, Wagner KF: Cutaneous thrombosis in human immunodeficiency virus type 1-positive patients and cytomegalovirus viremia. Arch Dermatiol 1995, 131:357-358.
36. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM: Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 1999, 13:347-355.
37. Ardiles L, Ramirez P, Moya P, et al.: Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo. Nephron 1999, 83:47-52.
38. Figueroa F, Berrios X, Gutierrez M, et al.: Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol 1992, 19:1175-1180.
39. Ilarraza H, Marquez MF, Alcocer A, et al.: Anticardiolipin antibodies are not associated with rheumatic heart disease. Lupus 2001, 10:873-875.
40. Snowden N, Wilson PB, Longson M, Pumphrey RS: Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J 1990, 66:356-362.
41. Bakshi M, Khemani C, Vishwanathan V, et al.: Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus. Lupus 2006, 15:105-106.
42. Witmer CM, Steenhoff AP, Shah SS, Raffini LJ: Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics 2007, 119:e292-295.
43. Goldenberg NA, Knapp-Clevenger R, Hays T, Manco-Johnson MJ: Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics 2005, 116:543-548.
44. Hojnik M, Gilburd B, Ziporen L, et al.: Anticardiolipin antibodies in infections are heterogenous in their dependency on beta2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 1994, 3:515-521.
45. De Larranaga GF, Forastiero RR, Martinuzzo ME, et al.: High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 2000, 9:594-600.
46. Consigny PH, Cauquelin B, Agnamey P, et al.: High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol 2002, 127:158-164.
47. Santiago M, Martinelli R, Ko A, et al.: Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 2001, 19:425-430.
48. Martinuc-Porobic J, Avcin T, Bozic B, et al.: Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005, 142:377-380.
49. Tarjan P, Sipka S, Lakos G, et al.: Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006, 35:241-249.
50. Mormile R, D'Alterio V, Treccagnoli G, Sorrentino P: Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children? Vaccine 2004, 23:567-568.
51. Blank M, Asherson RA, Cervera R, Shoenfeld Y: Antiphospholipid syndrome infectious origin. J Clin Immunol 2004, 24:12-23.
52. Blank M, Krause I, Fridkin M, et al.: Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002, 109:797-804.
53. Gharavi AE, Pierangeli SS, Espinola RG, et al.: Antiphospholipid antibodies induced in mice by immunization with cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002, 46:545-552.
54. Raschi E, Testoni C, Bosisio D, et al.: Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003, 101:3495-3500.
55. Pierangeli SS, Vega-Ostertag ME, Raschi E, et al.: Toll like receptor 4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann Rheum Dis 2007, in press.